Among the few notable exceptions to the Dow’s generally down day on Monday was Foster City’s Gilead Sciences Inc., which climbed nearly 4 percent to close at $47.53. Could have something to do with the royalties they’re collecting on Tamiflu, the influenza drug the biotech company invented and sold to Swiss pharma Roche Holding AG in 1996. Prepare For The Swine Flu – See Ba...

The “swine flu” will be around for months and months. The key to selecting a good stock for this issue is to find a company that is not in clinical stages. Find a stock that is reasonably priced and can support testing and cures. Here is our pick of the week… INOVIO BIOMEDICAL CORP COM (INO: AMEX) We believe this stock has the potential to hit over $2 in the next 4 or 5 months. ...